2 completed, 1 terminated. 3 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 3 | Completed 2, Terminated 1 |
| Phase 2 | 1 | Completed 1 |
Follow ferumoxides: new trials by email Literature Review of ferumoxides trials Research Report on ferumoxides
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Sentinel Node Localization and Staging with Low Dose Superparamagnetic Iron Oxide Superparamagnetic Iron Oxide - Breast Cancer, Sentinel Lymph Node | Phase 1 / Phase 2 | Completed | Vastra Gotaland Region | 50 | 2021-11-01 | 2025-03-28 |
| Ferumoxytol-enhanced Imaging of Osteomyelitis Ferumoxides 11.2Mg Solution for Injection - Osteomyelitis | Phase 1 | Completed | University of New Mexico | 12 | 2014-02-12 | 2023-07-25 |
| Islet of Langerhans Graft Monitoring by Magnetic Resonance Imaging ferucarbotran (iron-based MRI contrast agent), Islet transplantation, Magnetic resonance imaging - Type 1 Diabetes Mellitus | Phase 1 | Terminated | University Hospital, Geneva | 5 | 2005-06-01 | 2014-12-02 |
Breast Neoplasms (1) · Diabetes Mellitus, Type 1 (1) · Osteomyelitis (1)
University Hospital, Geneva (1) · University of New Mexico (1) · Vastra Gotaland Region (1)
Sweden (1) · Switzerland (1) · United States (1)
Laurel Sillerud, PhD (1) · Roger Olofsson Bagge, MD, PhD (1) · Thierry Berney, MD, MSc (1)